Your browser doesn't support javascript.
loading
A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology.
Voruganti, Sudhakar; Xu, Jiahui; Li, Xue; Balakrishnan, Gurusamy; Singh, Surinder M; Kar, Sambit R; Das, Tapan K.
Afiliação
  • Voruganti S; Bristol Myers Squibb, Analytical Development and Attribute Sciences, New Brunswick, NJ, USA.
  • Xu J; Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, United States; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Li X; Bristol Myers Squibb, Analytical Development and Attribute Sciences, New Brunswick, NJ, USA.
  • Balakrishnan G; Bristol Myers Squibb, Analytical Development and Attribute Sciences, New Brunswick, NJ, USA.
  • Singh SM; Bristol Myers Squibb, Analytical Development and Attribute Sciences, New Brunswick, NJ, USA.
  • Kar SR; Bristol Myers Squibb, Analytical Development and Attribute Sciences, New Brunswick, NJ, USA.
  • Das TK; Bristol Myers Squibb, Analytical Development and Attribute Sciences, New Brunswick, NJ, USA. Electronic address: dtapan1@yahoo.com.
J Pharm Sci ; 110(2): 935-945, 2021 02.
Article em En | MEDLINE | ID: mdl-33039440
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos Fc das Imunoglobulinas / Laboratórios Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragmentos Fc das Imunoglobulinas / Laboratórios Idioma: En Ano de publicação: 2021 Tipo de documento: Article